Proceeds from the announced financing will allow Acutus to increase market availability of the Company's FDA and CE marked AcQMap™ products as well as a suite of FDA-cleared, EP-designed vascular access products – AcQCross QX, AcQGuide Flex™ and AcQGuide Mini™.
"Cardiac ablation is a rapidly growing market and treatment efficiency needs to improve. Many people, including dear friends of ours, have faced these procedures and Acutus' innovative and effective tools look to add even more safety," said Drew Oetting, Founding Partner, 8VC. "At 8VC we believe in the power of technology and we are passionate about accelerating real and impactful change. We are confident in Acutus' and the leadership team's commitment to progressing until every patient has access to trusted, proven technology."
About Acutus Medical
Acutus Medical is a dynamic arrhythmia care company focused on developing distinct, innovative technologies designed to provide physicians and patients with improved results. At Acutus, we know that seeing is better than believing. Diagnosing and treating patients with atrial arrhythmias requires eliminating the unknown. Acutus' advanced cardiac imaging and mapping system provides real-time arrhythmia visualization displaying the heart's true activation pattern, turning the chaos of an atrial arrhythmia into a clear vision for electrophysiologists. Founded in 2011, Acutus is based in Carlsbad, California.
SOURCE Acutus Medical
Back to HCB News
